Creative Financial Designs Inc Invitae Corp Transaction History

Creative Financial Designs Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$0.0 - $0.01 $0 - $0	50 New	50 $0
Q3 2021 Oct 08, 2021	SELL	$24.31 - $33.6 $41,327 - $57,120	-1,700 Reduced 86.73%	260 $7,000
Q1 2021 Apr 19, 2021	SELL	$33.06 - $56.93 $16,530 - $28,465	-500 Reduced 20.33%	1,960 $75,000
Q4 2020 Jan 08, 2021	SELL	$39.09 - $57.4 $11,727 - $17,220	-300 Reduced 10.87%	2,460 $103,000
Q3 2020 Oct 06, 2020	BUY	$28.43 - $44.67 $17,058 - $26,802	600 Added 27.78%	2,760 $120,000
Q2 2020 Jul 23, 2020	BUY	$11.71 - $30.29 $25,293 - $65,426	2,160 New	2,160 $65,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

Stay updated on Creative Financial Designs Inc with notifications on news.